Genetically modified T-cell therapy in multicenter trials
Giving attention to the needs and voices of bone and marrow transplant patients
Transplant vs bortezomib and LEN/DEX in multiple myeloma
Have novel drugs made stem cell transplantation obsolete?
Frontline therapy and the role of high-dose consolidation in mantle cell lymphoma